Theravance Biopharma TBPH Increase Decrease In Right Of Use Assets
Increase Decrease In Right Of Use Assets at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept tbph:IncreaseDecreaseInRightOfUseAssets.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's increase decrease in right of use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's increase decrease in right of use assets?
- Theravance Biopharma (TBPH) reported increase decrease in right of use assets of -$314K in Q1 2026.
- How has Theravance Biopharma's increase decrease in right of use assets changed year-over-year?
- Theravance Biopharma's increase decrease in right of use assets decreased by 847.6% year-over-year, from $42K to -$314K.
- What does increase decrease in right of use assets mean?
- This captures the net change in the carrying value of right-of-use assets recognized under lease accounting standards. It reflects additions, modifications, or impairments of leased assets such as office space or laboratory facilities. Changes in this metric provide insight into the company's physical footprint and long-term lease commitments.